IL1B and osteoarthritis: In this study, we took advantage of IL‐1β‐induced osteoarthritis chondrocyte degeneration to model osteoarthritis progression in vitro and confirmed that treatment of osteoarthritis chondrocytes leads to reduced chondrocyte viability, increased production of ECM degradation markers, and inflammatory mediators and increased oxidative stress.